These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3949798)

  • 1. Neutralization of heparin-related saccharides by histidine-rich glycoprotein and platelet factor 4.
    Lane DA; Pejler G; Flynn AM; Thompson EA; Lindahl U
    J Biol Chem; 1986 Mar; 261(9):3980-6. PubMed ID: 3949798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural requirements for the neutralization of heparin-like saccharides by complement S protein/vitronectin.
    Lane DA; Flynn AM; Pejler G; Lindahl U; Choay J; Preissner K
    J Biol Chem; 1987 Dec; 262(34):16343-8. PubMed ID: 2445746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4.
    Lane DA; Denton J; Flynn AM; Thunberg L; Lindahl U
    Biochem J; 1984 Mar; 218(3):725-32. PubMed ID: 6721831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of size, sulfation, and anticoagulant activity in the potentiation of acidic fibroblast growth factor by heparin.
    Sudhalter J; Folkman J; Svahn CM; Bergendal K; D'Amore PA
    J Biol Chem; 1989 Apr; 264(12):6892-7. PubMed ID: 2708348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biosynthesis of heparin/heparan sulfate. The D-glucosaminyl 3-O-sulfotransferase reaction: target and inhibitor saccharides.
    Razi N; Lindahl U
    J Biol Chem; 1995 May; 270(19):11267-75. PubMed ID: 7744762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of platelet factor 4 to heparin oligosaccharides.
    Denton J; Lane DA; Thunberg L; Slater AM; Lindahl U
    Biochem J; 1983 Feb; 209(2):455-60. PubMed ID: 6847629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histidine-rich glycoprotein does not interfere with interactions between antithrombin III and heparin-like compounds on vascular endothelial cells.
    Shimada K; Kawamoto A; Matsubayashi K; Ozawa T
    Blood; 1989 Jan; 73(1):191-3. PubMed ID: 2910359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of heparin cofactor II activity by histidine-rich glycoprotein and platelet factor 4.
    Tollefsen DM; Pestka CA
    J Clin Invest; 1985 Feb; 75(2):496-501. PubMed ID: 3838317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histidine-rich glycoprotein and platelet factor 4 mask heparan sulfate proteoglycans recognized by acidic and basic fibroblast growth factor.
    Brown KJ; Parish CR
    Biochemistry; 1994 Nov; 33(46):13918-27. PubMed ID: 7524669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mode of interaction between platelet factor 4 and heparin.
    Maccarana M; Lindahl U
    Glycobiology; 1993 Jun; 3(3):271-7. PubMed ID: 8358152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin binding properties of human histidine-rich glycoprotein. Mechanism and role in the neutralization of heparin in plasma.
    Lijnen HR; Hoylaerts M; Collen D
    J Biol Chem; 1983 Mar; 258(6):3803-8. PubMed ID: 6833231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-thrombin activities of heparin. Effect of saccharide chain length on thrombin inhibition by heparin cofactor II and by antithrombin.
    Bray B; Lane DA; Freyssinet JM; Pejler G; Lindahl U
    Biochem J; 1989 Aug; 262(1):225-32. PubMed ID: 2818566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of heparin with histidine-rich glycoprotein and with antithrombin III.
    Lijnen HR; van Hoef B; Collen D
    Thromb Haemost; 1983 Aug; 50(2):560-2. PubMed ID: 6415849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzymatic preparation of heparin oligosaccharides containing antithrombin III binding sites.
    Toida T; Hileman RE; Smith AE; Vlahova PI; Linhardt RJ
    J Biol Chem; 1996 Dec; 271(50):32040-7. PubMed ID: 8943254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of fibroblast growth factor-1 and related peptides with heparan sulfate and its oligosaccharides.
    Fromm JR; Hileman RE; Weiler JM; Linhardt RJ
    Arch Biochem Biophys; 1997 Oct; 346(2):252-62. PubMed ID: 9343372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biosynthesis of heparin. Enzymatic sulfation of pentasaccharides.
    Kusche M; Oscarsson LG; Reynertson R; Rodén L; Lindahl U
    J Biol Chem; 1991 Apr; 266(12):7400-9. PubMed ID: 1902219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple functional domains of the heparin molecule.
    Oosta GM; Gardner WT; Beeler DL; Rosenberg RD
    Proc Natl Acad Sci U S A; 1981 Feb; 78(2):829-33. PubMed ID: 6940150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement.
    Olson ST; Björk I; Sheffer R; Craig PA; Shore JD; Choay J
    J Biol Chem; 1992 Jun; 267(18):12528-38. PubMed ID: 1618758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific heparan sulfate saccharides mediate the activity of basic fibroblast growth factor.
    Walker A; Turnbull JE; Gallagher JT
    J Biol Chem; 1994 Jan; 269(2):931-5. PubMed ID: 8288646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Requirement for anticoagulant heparan sulfate in the fibroblast growth factor receptor complex.
    McKeehan WL; Wu X; Kan M
    J Biol Chem; 1999 Jul; 274(31):21511-4. PubMed ID: 10419453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.